The obtained data mostly correspond well with the literature, according to which the prevalence of RPE65-associated retinopathy among patients with different retinitis pigmentosa types (confirmed via molecular genetic means) in Europe and North America varied from 3% in the USA and Spain to 9.98% in the Netherlands [32]. This evidence concerns the gene RPE65 and retinitis pigmentosa.